Molecular insights on basal-like breast cancer (Q34123314)

31 July 2017

Molecular insights on basal-like breast cancer. (English)

1 reference

31 July 2017

1 reference

Mev Dominguez Valentin

1

1 reference

31 July 2017

Sabrina Daniela da Silva

2

1 reference

31 July 2017

Maud Privat

3

1 reference

31 July 2017

Moulay Alaoui-Jamali

4

1 reference

31 July 2017

Yves-Jean Bignon

5

1 reference

31 July 2017

language of work or name

English

0 references

publication date

11 January 2012

1 reference

Breast Cancer Research and Treatment

31 July 2017

1 reference

31 July 2017

134

1 reference

31 July 2017

21-30

1 reference

31 July 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s10549-011-1934-z

31 July 2017

0 references

cites work

Prognostic markers in triple-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Molecular portraits of human breast tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Deconstructing the molecular portrait of basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

What is triple-negative breast cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Triple-negative breast cancer: distinguishing between basal and nonbasal subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Triple-negative breast cancer: risk factors to potential targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Characterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Identification of molecular apocrine breast tumours by microarray analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Breast cancer precursors revisited: molecular features and progression pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Repeated observation of breast tumor subtypes in independent gene expression data sets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part I: Normal breast and benign proliferative lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Biomarkers for Basal-like Breast Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Wnt/beta-catenin pathway activation is enriched in basal-like breast cancers and predicts poor outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Wnt signaling pathway in mammary gland development and carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Triple-negative breast carcinoma--rewiev of current literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Basal-like breast cancer: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Genomic instability in breast cancer: pathogenesis and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Minireview: Basal-like breast cancer: from molecular profiles to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Integrated profiling of basal and luminal breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Loss of heterozygosity and its correlation with expression profiles in subclasses of invasive breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

DNA hypermethylation in breast cancer and its association with clinicopathological features.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Subtypes of familial breast tumours revealed by expression and copy number profiling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Molecular classification of familial non-BRCA1/BRCA2 breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Molecular portraits of breast cancer: tumour subtypes as distinct disease entities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Impact of basal-like breast carcinoma determination for a more specific therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

The complex relationship between BRCA1 and ERalpha in hereditary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

FOXC1 is a potential prognostic biomarker with functional significance in basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Clinicopathological features and treatment strategy for triple-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Basal-like subtype of breast cancer: a review of its unique characteristics and their clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Epidemiology of basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Synthetic lethality through combined Notch-epidermal growth factor receptor pathway inhibition in basal-like breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Vimentin and laminin expression is associated with basal-like phenotype in both sporadic and BRCA1-associated breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Nestin is expressed in the basal/myoepithelial layer of the mammary gland and is a selective marker of basal epithelial breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Nestin is expressed in basal-like and triple negative breast cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Moesin expression is a marker of basal breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Caveolin 1 and Caveolin 2 are associated with breast cancer basal-like and triple-negative immunophenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Caveolin 1 is overexpressed and amplified in a subset of basal-like and metaplastic breast carcinomas: a morphologic, ultrastructural, immunohistochemical, and in situ hybridization analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Analysis of integrin beta4 expression in human breast cancer: association with basal-like tumors and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Distribution and significance of nerve growth factor receptor (NGFR/p75NTR) in normal, benign and malignant breast tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

CD109 expression in basal-like breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

p63, cytokeratin 5, and P-cadherin: three molecular markers to distinguish basal phenotype in breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

P-cadherin and cytokeratin 5: useful adjunct markers to distinguish basal-like ductal carcinomas in situ.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Invasive ductal carcinoma of the breast with the "triple-negative" phenotype: prognostic implications of EGFR immunoreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Mesenchyme Forkhead 1 (FOXC2) plays a key role in metastasis and is associated with aggressive basal-like breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Overexpression of E2F-5 correlates with a pathological basal phenotype and a worse clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

p63 correlates with both BRCA1 and cytokeratin 5 in invasive breast carcinomas: further evidence for the pathogenesis of the basal phenotype of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Basal cytokeratin expression in relation to biological factors in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

The proteins FABP7 and OATP2 are associated with the basal phenotype and patient outcome in human breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

Overexpression of fatty acid binding protein-7 correlates with basal-like subtype of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

AlphaB-crystallin: a novel marker of invasive basal-like and metaplastic breast carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-011-1934-Z

10.1007/S10549-011-1934-Z

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

0 references

1 reference